Table: Kobayashi Pharmaceutical -2024 group results

Kobayashi Pharmaceutical

10/02/2025 06:31

Feb 10 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2024    Dec 31, 2023   Dec 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          165.60          173.46         171.00                 
               (-4.5 pct)      (+4.3 pct)     (+3.3 pct)               
  Operating       24.86           25.78          14.00                 
               (-3.6 pct)      (-3.3 pct)     (-43.7 pct)              
  Recurring       26.86           27.33          15.30                 
               (-1.7 pct)      (-3.4 pct)     (-43.0 pct)              
  Net
  Net             10.07           20.34          10.50                 
               (-50.5 pct)     (+1.6 pct)     (+4.3 pct)               
  EPS          135.42 yen      268.16 yen     141.25 yen               
  Ann Div      102.00 yen      101.00 yen     104.00 yen               
  -Q2 Div       43.00 yen       43.00 yen      44.00 yen               
  -Q4 Div       59.00 yen       58.00 yen      60.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T